Qingdao Haier Biomedical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 8.63%

Qingdao Haier Biomedical Co Ltd (688139) has an Asset Resilience Ratio of 8.63% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 688139 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥505.41 Million

≈ $73.96 Million USD Cash + Short-term Investments

Total Assets

CN¥5.86 Billion

≈ $856.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Qingdao Haier Biomedical Co Ltd's Asset Resilience Ratio has changed over time. See 688139 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Qingdao Haier Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Qingdao Haier Biomedical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥505.41 Million	8.63%
Total Liquid Assets	CN¥505.41 Million	8.63%

Asset Resilience Insights

Limited Liquidity: Qingdao Haier Biomedical Co Ltd maintains only 8.63% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qingdao Haier Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Qingdao Haier Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Shanghai MicroPort EV MedTech Co. Ltd. A SHG:688351	Medical Devices	49.23%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
Shenzhen Lifotronic Technology Co SHG:688389	Medical Devices	2.53%
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	Medical Devices	0.84%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%

Annual Asset Resilience Ratio for Qingdao Haier Biomedical Co Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Qingdao Haier Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.73%	CN¥447.59 Million ≈ $65.50 Million	CN¥5.79 Billion ≈ $847.48 Million	-7.43pp
2024-12-31	15.16%	CN¥877.25 Million ≈ $128.37 Million	CN¥5.79 Billion ≈ $846.89 Million	+3.37pp
2023-12-31	11.78%	CN¥651.14 Million ≈ $95.28 Million	CN¥5.53 Billion ≈ $808.58 Million	-25.08pp
2022-12-31	36.87%	CN¥2.02 Billion ≈ $296.12 Million	CN¥5.49 Billion ≈ $803.21 Million	-6.60pp
2021-12-31	43.47%	CN¥2.13 Billion ≈ $311.65 Million	CN¥4.90 Billion ≈ $717.00 Million	+33.12pp
2020-12-31	10.35%	CN¥408.03 Million ≈ $59.71 Million	CN¥3.94 Billion ≈ $576.93 Million	+5.97pp
2019-12-31	4.38%	CN¥133.05 Million ≈ $19.47 Million	CN¥3.04 Billion ≈ $444.85 Million	--

pp = percentage points

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.24 Billion

CN¥8.44 Billion CNY

Market Cap Rank

#8159 Global

#1964 in China

Share Price

CN¥26.67

Change (1 day)

-1.22%

52-Week Range

CN¥26.40 - CN¥37.36

All Time High

CN¥147.76